ARCHIVES

Also Weber returns to M.D. Anderson.

This article is from The Cancer Letter archive.

Vol. 29 No. 32 | August 8, 2003

Download PDF Visit The Full Archive

Related Articles

Investigators Plan To Interview DeVita, Mendelsohn on C225 Development

July 5, 2002

Wyngaarden says NCI’s Special Authorities Are All Right With Him

May 14, 1982

Clinical Research: Enough Studies Done, Time For Solutions, CSR Report Says

February 20, 1998

60 Minutes To Air Segment On The “Deception at Duke”

February 10, 2012

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

NCI Forms New Committees to Oversee Cancer Clinical Trials.

February 17, 2006